Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2−/− mice-Reference-Cited by-同舟云学术

Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2−/− mice

Published:2009-02-08 Issue:6 Volume:49 Page:1972-1981
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Halilbasic Emina,Fiorotto Romina,Fickert Peter,Marschall Hanns-Ulrich,Moustafa Tarek,Spirli Carlo,Fuchsbichler Andrea,Gumhold Judith,Silbert Dagmar,Zatloukal Kurt,Langner Cord,Maitra Uday,Denk Helmut,Hofmann Alan F.,Strazzabosco Mario,Trauner Michael

Publisher

Wiley

Subject

Hepatology

Reference29 articles.

1. Guidelines for therapy of autoimmune liver disease;Ishibashi;Semin Liver Dis,2007

2. The cholangiopathies: disorders of biliary epithelia;Lazaridis;Gastroenterology,2004

3. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles;Fickert;Gastroenterology,2002

4. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice;Fickert;Gastroenterology,2004

5. MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes;Trauner;Semin Liver Dis,2007

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cholangiocyte Organoids: The New Frontier in Regenerative Medicine for the Study and Treatment of Cholangiopathies;Journal of Clinical Medicine;2024-03-21

2. Novel preclinical developments of the primary sclerosing cholangitis treatment landscape;Expert Opinion on Investigational Drugs;2024-03-18

3. Cellular Interactions and Crosstalk Facilitating Biliary Fibrosis in Cholestasis;Cellular and Molecular Gastroenterology and Hepatology;2024

4. Current and future opportunities for the management of primary biliary cholangitis;Frontiers in Gastroenterology;2023-12-04

5. 24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγ;JHEP Reports;2023-11